skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 1,248  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes
Material Type:
Article
Add to My Research

Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes

The New England journal of medicine, 2020-06, Vol.382 (26), p.2493-2503 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1916624 ;PMID: 32579810

Full text available

2
Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
Material Type:
Article
Add to My Research

Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout

The New England journal of medicine, 2018-03, Vol.378 (13), p.1200-1210 [Peer Reviewed Journal]

Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1710895 ;PMID: 29527974

Full text available

3
Effects of Allopurinol on the Progression of Chronic Kidney Disease
Material Type:
Article
Add to My Research

Effects of Allopurinol on the Progression of Chronic Kidney Disease

The New England journal of medicine, 2020-06, Vol.382 (26), p.2504-2513 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1915833 ;PMID: 32579811

Full text available

4
Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial
Material Type:
Article
Add to My Research

Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial

The Lancet (British edition), 2022-10, Vol.400 (10359), p.1195-1205 [Peer Reviewed Journal]

2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2022. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)01657-9 ;PMID: 36216006

Full text available

5
Anti-inflammatory therapies for atherosclerosis
Material Type:
Article
Add to My Research

Anti-inflammatory therapies for atherosclerosis

Nature reviews cardiology, 2015-04, Vol.12 (4), p.199-211 [Peer Reviewed Journal]

COPYRIGHT 2015 Nature Publishing Group ;COPYRIGHT 2015 Nature Publishing Group ;Copyright Nature Publishing Group Apr 2015 ;ISSN: 1759-5002 ;ISSN: 1759-5010 ;EISSN: 1759-5010 ;DOI: 10.1038/nrcardio.2015.5 ;PMID: 25666404

Full text available

6
Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study
Material Type:
Article
Add to My Research

Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study

Circulation (New York, N.Y.), 2015-05, Vol.131 (20), p.1763-1771 [Peer Reviewed Journal]

2015 American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.114.014536 ;PMID: 25986447

Full text available

7
Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol: Population-Based Cohort Study
Material Type:
Article
Add to My Research

Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol: Population-Based Cohort Study

Circulation (New York, N.Y.), 2018-09, Vol.138 (11), p.1116-1126 [Peer Reviewed Journal]

2018 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.118.033992 ;PMID: 29899013

Full text available

8
Patients with gout adhere to curative treatment if informed appropriately: proof-of-concept observational study
Material Type:
Article
Add to My Research

Patients with gout adhere to curative treatment if informed appropriately: proof-of-concept observational study

Annals of the rheumatic diseases, 2013-06, Vol.72 (6), p.826-830 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Copyright: 2013 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2012-201676 ;PMID: 22679303 ;CODEN: ARDIAO

Full text available

9
Combination Treatment with Verinurad and Allopurinol in CKD: A Randomized Placebo and Active Controlled Trial
Material Type:
Article
Add to My Research

Combination Treatment with Verinurad and Allopurinol in CKD: A Randomized Placebo and Active Controlled Trial

Journal of the American Society of Nephrology, 2024-05, Vol.35 (5), p.594-606 [Peer Reviewed Journal]

EISSN: 1533-3450 ;DOI: 10.1681/ASN.0000000000000326 ;PMID: 38564654

Full text available

10
Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study)
Material Type:
Article
Add to My Research

Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study)

Annals of the rheumatic diseases, 2017-05, Vol.76 (5), p.811-820 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/. ;Copyright: 2016 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ 2016 ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2016-209213 ;PMID: 27821644 ;CODEN: ARDIAO

Full text available

11
Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis
Material Type:
Article
Add to My Research

Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis

Nephrology, dialysis, transplantation, 2014-02, Vol.29 (2), p.406-413 [Peer Reviewed Journal]

ISSN: 0931-0509 ;EISSN: 1460-2385 ;DOI: 10.1093/ndt/gft378 ;PMID: 24042021

Full text available

12
Allopurinol does not improve cardiovascular outcomes in ischaemic heart disease
Material Type:
Article
Add to My Research

Allopurinol does not improve cardiovascular outcomes in ischaemic heart disease

European heart journal, 2023-03, Vol.44 (12), p.1016-1017 [Peer Reviewed Journal]

ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehad014 ;PMID: 36733214

Full text available

13
Serum urate outcomes of treat-to-target urate lowering treatment: results of a nationwide cohort study from 1997 to the COVID-19 pandemic using data from the Clinical Practice Research Datalink
Material Type:
Article
Add to My Research

Serum urate outcomes of treat-to-target urate lowering treatment: results of a nationwide cohort study from 1997 to the COVID-19 pandemic using data from the Clinical Practice Research Datalink

Annals of the rheumatic diseases, 2022-12, Vol.81 (12), p.1768-1769 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/ard-2022-222668 ;PMID: 35772867

Full text available

14
Uric Acid Reduction Rectifies Prehypertension in Obese Adolescents
Material Type:
Article
Add to My Research

Uric Acid Reduction Rectifies Prehypertension in Obese Adolescents

Hypertension (Dallas, Tex. 1979), 2012-11, Vol.60 (5), p.1148-1156 [Peer Reviewed Journal]

2012 American Heart Association, Inc. ;2015 INIST-CNRS ;ISSN: 0194-911X ;EISSN: 1524-4563 ;DOI: 10.1161/HYPERTENSIONAHA.112.196980 ;PMID: 23006736 ;CODEN: HPRTDN

Full text available

15
A Randomized, Double‐Blind, Active‐ and Placebo‐Controlled Efficacy and Safety Study of Arhalofenate for Reducing Flare in Patients With Gout
Material Type:
Article
Add to My Research

A Randomized, Double‐Blind, Active‐ and Placebo‐Controlled Efficacy and Safety Study of Arhalofenate for Reducing Flare in Patients With Gout

Arthritis & rheumatology (Hoboken, N.J.), 2016-08, Vol.68 (8), p.2027-2034 [Peer Reviewed Journal]

2016 The Authors. Arthritis & Rheumatology published by Wiley Periodicals, Inc. on behalf of the American College of Rheumatology. ;2016, American College of Rheumatology ;ISSN: 2326-5191 ;EISSN: 2326-5205 ;DOI: 10.1002/art.39684 ;PMID: 26989892

Full text available

16
Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk
Material Type:
Article
Add to My Research

Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk

Clinical journal of the American Society of Nephrology, 2010-08, Vol.5 (8), p.1388-1393 [Peer Reviewed Journal]

Copyright © 2010 by the American Society of Nephrology ;ISSN: 1555-9041 ;EISSN: 1555-905X ;DOI: 10.2215/CJN.01580210 ;PMID: 20538833

Full text available

17
Allopurinol treatment improves renal function in patients with type 2 diabetes and asymptomatic hyperuricemia: 3-year randomized parallel-controlled study
Material Type:
Article
Add to My Research

Allopurinol treatment improves renal function in patients with type 2 diabetes and asymptomatic hyperuricemia: 3-year randomized parallel-controlled study

Clinical endocrinology (Oxford), 2015-10, Vol.83 (4), p.475-482 [Peer Reviewed Journal]

2014 John Wiley & Sons Ltd ;2014 John Wiley & Sons Ltd. ;Copyright © 2015 John Wiley & Sons Ltd ;ISSN: 0300-0664 ;EISSN: 1365-2265 ;DOI: 10.1111/cen.12673 ;PMID: 25400252

Full text available

18
Lowering Uric Acid With Allopurinol Improves Insulin Resistance and Systemic Inflammation in Asymptomatic Hyperuricemia
Material Type:
Article
Add to My Research

Lowering Uric Acid With Allopurinol Improves Insulin Resistance and Systemic Inflammation in Asymptomatic Hyperuricemia

Journal of investigative medicine, 2015-12, Vol.63 (8), p.924-929 [Peer Reviewed Journal]

2015 American Federation for Medical Research, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;2015 American Federation for Medical Research ;Copyright: 2015 (c) 2015 American Federation for Medical Research, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;ISSN: 1081-5589 ;EISSN: 1708-8267 ;DOI: 10.1097/JIM.0000000000000242 ;PMID: 26571421

Full text available

19
Therapeutic Effects of Xanthine Oxidase Inhibitors: Renaissance Half a Century after the Discovery of Allopurinol
Material Type:
Article
Add to My Research

Therapeutic Effects of Xanthine Oxidase Inhibitors: Renaissance Half a Century after the Discovery of Allopurinol

Pharmacological reviews, 2006-03, Vol.58 (1), p.87-114 [Peer Reviewed Journal]

ISSN: 0031-6997 ;EISSN: 1521-0081 ;DOI: 10.1124/pr.58.1.6 ;PMID: 16507884

Full text available

20
Acquired reactive perforating dermatosis successfully treated with allopurinol
Material Type:
Article
Add to My Research

Acquired reactive perforating dermatosis successfully treated with allopurinol

Anais brasileiros de dermatología, 2024-01, Vol.99 (1), p.148-149 [Peer Reviewed Journal]

2023 Sociedade Brasileira de Dermatologia ;2023 Sociedade Brasileira de Dermatologia. Published by Elsevier España, S.L.U. 2023 Sociedade Brasileira de Dermatologia ;This work is licensed under a Creative Commons Attribution 4.0 International License. ;ISSN: 0365-0596 ;ISSN: 1806-4841 ;EISSN: 1806-4841 ;DOI: 10.1016/j.abd.2022.06.009 ;PMID: 37722994

Full text available

Results 1 - 20 of 1,248  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (1,134)

Refine My Results

Creation Date 

From To
  1. Before 1977  (144)
  2. 1977 To 1988  (170)
  3. 1989 To 2000  (223)
  4. 2001 To 2013  (396)
  5. After 2013  (317)
  6. More options open sub menu

Resource Type 

  1. Articles  (1,246)
  2. magazinearticle  (2)
  3. More options open sub menu

Language 

  1. English  (1,205)
  2. Japanese  (151)
  3. Spanish  (18)
  4. German  (14)
  5. Portuguese  (11)
  6. French  (7)
  7. Russian  (5)
  8. Serbian  (2)
  9. Polish  (1)
  10. Italian  (1)
  11. Norwegian  (1)
  12. Korean  (1)
  13. Chinese  (1)
  14. More options open sub menu

Searching Remote Databases, Please Wait